Unknown Analyst

I'm on the Bank of America Life Science Tools and Diagnostics team. I'm excited to be hosting IQVIA for our next fireside chat. I'm joined by Mike Fedock, Chief Financial Officer. Mike, thanks so much for being here.

Michael Fedock
Executive VP & Chief Financial Officer

Great to be here.

Unknown Analyst

Usual format will be a fireside Q&A. If anyone's got a burning question, feel free to raise your hand, and we'll throw it in.

Unknown Analyst

Mike, maybe just to kick things off, you recently reported 1Q just about a week ago. What were the key takeaways from the quarter? How has that impacted your confidence in the rest of the year? And just sort of any read-throughs from that?

Michael Fedock
Executive VP & Chief Financial Officer

Sure. Yes. We were very pleased with our print and the performance in the quarter. Starting out a year with revenue and EPS above the high end of our expectations was great. Also being able to show the Street the strong organic revenue growth acceleration in both Commercial Solutions and RDS. I think Commercial Solutions organic revenue grew 2x versus the prior year and RDS more than 3x.

And given the AI fears that were out there, it was really good, and we got some -- a lot of good feedback from investors that our theory about the durability and AI being a tailwind for us was actually playing out in the numbers, which was great.

And from an RDS standpoint to deliver just about $2.5 billion in net bookings and double-digit growth in the bookings year-on-year. And